Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q2 2026)
6,967
Value
$260.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CRNX by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,967$260.7K<0.1%−94−1.3%ReducedHolders
Q1 20267,061$256.5K<0.1%+1,550+28.1%AddedHolders
Q4 20255,511$256.5K<0.1%+405+7.9%AddedHolders
Q3 20255,106$212.7K<0.1%+202+4.1%AddedHolders
Q2 20254,904$141.0K<0.1%+171+3.6%AddedHolders
Q1 20254,733$158.7K<0.1%−1,579−25.0%ReducedHolders
Q4 20246,312$322.7K<0.1%−5,176−45.1%ReducedHolders
Q3 202411,488$587.0K<0.1%+373+3.4%AddedHolders
Q2 202411,115$497.8K<0.1%+6,952+167.0%AddedHolders
Q1 20244,163$194.9K<0.1%+3,958+1,930.7%AddedHolders
Q4 2023205$7.29K<0.1%−8,786−97.7%ReducedHolders
Q3 20238,991$267.4K<0.1%+8,928+14,171.4%AddedHolders
Q2 202363$1.14K<0.1%−87−58.0%ReducedHolders
Q1 2023150$2.41K<0.1%+87+138.1%AddedHolders
Q4 202263$1.15K<0.1%−18−22.2%ReducedHolders
Q3 202281$2.00K<0.1%+18+28.6%AddedHolders
Q2 202263$1.00K<0.1%00.0%UnchangedHolders
Q1 202263$1.00K<0.1%00.0%UnchangedHolders
Q4 202163$2.00K<0.1%00.0%UnchangedHolders
Q3 202163$1.00K<0.1%−128−67.0%ReducedHolders
Q2 2021191$4.00K<0.1%+77+67.5%AddedHolders
Q1 2021114$2.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.